Central extracorporeal life support in pheochromocytoma crisis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22450084.
- Also identified by DOI 10.1016/j.athoracsur.2011.09.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pheochromocytoma is a catecholamine-secreting tumor associated with clinical presentations ranging from paroxysmal hypertension to intractable cardiogenic shock. We report the use of central extracorporeal life support (ECLS) in a young woman admitted to the intensive care unit with cardiogenic shock. Her medical history included neurofibromatosis type I and pheochromocytoma. ECLS was needed because of severe left ventricular failure and inotropic therapy unresponsiveness. ECLS permitted full recovery of left ventricular function. Right adrenelectomy was performed 4 months later. In this case, central ECLS was used to treat pheochromocytoma-induced cardiogenic shock complicated by pulmonary edema.
Medical subject headings
- Extracorporeal Membrane Oxygenation
- Neurofibromatosis 1
- Pheochromocytoma
- Pulmonary Edema
- Shock, Cardiogenic